In fact, for the BD+IL-6+LT group with non-steatotic livers, the liver injury parameters (levels of transaminases, damage scores, ALP, levels of total bilirubin, vWF, and HA; Figure 4) and inflammation indicators (MPO, edema, and MDA; Figure 5) were lower than those of the BD+LT group, while no changes were observed in those same experimental groups (BD+IL-6+LT and BD+LT) when steatotic grafts were used, when they were compared. The gene discussed is IL6; the disease is Behcet disease.